StockNews.com assumed coverage on shares of Aethlon Medical (NASDAQ:AEMD – Free Report) in a report issued on Thursday. The brokerage issued a sell rating on the medical equipment provider’s stock.
Aethlon Medical Price Performance
Shares of AEMD opened at $0.38 on Thursday. The stock has a market capitalization of $5.36 million, a price-to-earnings ratio of -0.10 and a beta of 1.74. Aethlon Medical has a 1 year low of $0.24 and a 1 year high of $2.35. The business’s 50 day simple moving average is $0.40 and its 200-day simple moving average is $0.55.
Aethlon Medical (NASDAQ:AEMD – Get Free Report) last issued its quarterly earnings data on Wednesday, August 14th. The medical equipment provider reported ($0.34) EPS for the quarter, topping analysts’ consensus estimates of ($0.44) by $0.10. During the same quarter in the previous year, the firm earned ($1.30) earnings per share. On average, sell-side analysts expect that Aethlon Medical will post -1.1 earnings per share for the current year.
Aethlon Medical Company Profile
Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.
Read More
- Five stocks we like better than Aethlon Medical
- 3 Warren Buffett Stocks to Buy Now
- From PACs to Portfolios: Billionaire Bets and Investor Reactions
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- AppLovin Stock Quadruples: What’s Behind the Bullish Sentiment?
- Insider Trades May Not Tell You What You Think
- Battle of the Retailers: Who Comes Out on Top?
Receive News & Ratings for Aethlon Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical and related companies with MarketBeat.com's FREE daily email newsletter.
